Comparison of analgesic effect with ropivacaine as intercostal nerve blocker on patients underwent video-assisted thoracic surgery between analgesia in advance and analgesia in the end of operation

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900024877

Enrollment

Unknown

Registered

2019-08-01

Start date

2019-08-05

Completion date

Unknown

Last updated

2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

analgesia

Interventions

one:advanced intercostal nerve block with Ropivacaine + PCIA

two:intercostal analgesia with Ropivacaine at the end of surgery + PCIA

three:PCIA

Eligibility

Sex/Gender

All

Age

35 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients admitted to hospital from January 2018 to December 2018, aged 35-75 years with American Society of Anesthesiologists physical status I-II and scheduled for elective VATS, including pulmonary lobectomy, pulmonary segmentectomy, pulmonary wedge resection, mediastinal tumor resection.

Exclusion criteria

Exclusion criteria: Previous history of thoracotomy surgery, history of severe alcoholism, preoperative serious dysfunction of heart, lung, liver and kidney; patients who were unable to cooperate with the investigator intraoperative conversion from minimally invasive surgery to open thoracotomy, operation time >3 hours, intraoperative bleeding >1000ml, reintubation or reoperation due to various complications, and incision infection.

Design outcomes

Primary

Measure	Time frame
VAS;PHPS;	—

Countries

China

Contacts

Public ContactXiao Weizhang

Affiliated Hospital of Nantong University

xwz191201@163.com+86 15996546951

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026